{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:10Z","timestamp":1788782890369,"version":"build-2803163510"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU \/2025\/01\/36575"],"award-info":[{"award-number":["PSAU \/2025\/01\/36575"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.apradiso.2026.112838","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:28:20Z","timestamp":1785281300000},"page":"112838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Maximizing nuclear capture and fission reactions: The innovative potential of boron delivery agents for neutron capture therapy in cancer treatment"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7179-2290","authenticated-orcid":false,"given":"Amr A.","family":"Abd-Elghany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3760-1235","authenticated-orcid":false,"given":"Amal I.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.M.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan M.","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtesam A.","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-3548","authenticated-orcid":false,"given":"Hosam M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.apradiso.2026.112838_bib1","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.3390\/cells11244029","article-title":"Boron vehiculating nanosystems for neutron capture therapy in cancer treatment","volume":"11","author":"Ailuno","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2022.109617","article-title":"Study to molecular insight into the role of aluminum nitride nanotubes on to deliver of 5-Fluorouracil (5FU) drug in smart drug delivery","volume":"142","author":"Al-Zuhairy","year":"2022","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.nano.2014.12.004","article-title":"A theranostic approach based on the use of a dual boron\/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment","volume":"11","author":"Alberti","year":"2015","journal-title":"Nanomedicine Nanotechnology, Biol. Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/molecules25040828","article-title":"Boron chemistry for medical applications","volume":"25","author":"Ali","year":"2020","journal-title":"Molecules"},{"issue":"49","key":"10.1016\/j.apradiso.2026.112838_bib5","doi-asserted-by":"crossref","first-page":"25914","DOI":"10.1002\/anie.202109835","article-title":"Diazaborines are a versatile platform to develop ROS\u2010Responsive antibody drug conjugates","volume":"60","author":"Ant\u00f3nio","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.apradiso.2026.112838_bib6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1535-7163.MCT-05-0161","article-title":"Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature","volume":"4","author":"Backer","year":"2005","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.apradiso.2026.112838_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s43673-022-00063-2","article-title":"Advances of LINAC-based boron neutron capture therapy in Korea","volume":"32","author":"Bae","year":"2022","journal-title":"AAPPS Bull."},{"key":"10.1016\/j.apradiso.2026.112838_bib8","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-05-0035","article-title":"Boron neutron capture therapy of cancer: current status and future prospects","volume":"11","author":"Barth","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/cac2.12582","article-title":"Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT","volume":"44","author":"Barth","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib10","first-page":"1","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/07357909609076899","article-title":"Boron neutron capture therapy of brain tumors: past history, Current status, and future potential","volume":"14","author":"Barth","year":"1996","journal-title":"Cancer Invest."},{"key":"10.1016\/j.apradiso.2026.112838_bib12","series-title":"Current Status of Boron Neutron Capture Therapy of High Grade Gliomas and Recurrent Head and Neck Cancer 1\u201321","author":"Barth","year":"2012"},{"issue":"45","key":"10.1016\/j.apradiso.2026.112838_bib13","doi-asserted-by":"crossref","first-page":"17493","DOI":"10.1073\/pnas.0809569105","article-title":"Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors","volume":"105","author":"Barth","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib14","first-page":"1","article-title":"A realistic appraisal of boron neutron capture therapy as a cancer treatment modality","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib15","series-title":"Advances in Neutron Capture Therapy","year":"1993"},{"key":"10.1016\/j.apradiso.2026.112838_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2019.109029","article-title":"Boron neutron capture therapy at the crossroads-where do we go from here?","volume":"160","author":"Barth","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112838_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113951","article-title":"Rationally designed drug delivery systems for the local treatment of resected glioblastoma","volume":"177","author":"Bastiancich","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib18","series-title":"Improvements, Validation, and Applications of a Metaheuristic Optimization Method for Neutron Spectra Tailoring at the National Ignition Facility","author":"Bogetic","year":"2020"},{"key":"10.1016\/j.apradiso.2026.112838_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","article-title":"Beyond conventional immune-checkpoint inhibition\u2014novel immunotherapies for renal cell carcinoma","volume":"18","author":"Braun","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.apradiso.2026.112838_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drudis.2011.09.014","article-title":"The formulation of polyhedral boranes for the boron neutron capture therapy of cancer","volume":"17","author":"Calabrese","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.apradiso.2026.112838_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1021\/bc950077q","article-title":"Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors","volume":"7","author":"Capala","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib22","article-title":"Neutron capture therapy: the promise of novel agents and medical facility-based neutron sources","author":"Capala","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.apradiso.2026.112838_bib23","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1038\/ncomms4546","article-title":"Porphyrin\u2013phospholipid liposomes permeabilized by near-infrared light","volume":"5","author":"Carter","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/nnm-2020-0401","article-title":"Boron-enriched polyvinyl-alcohol\/boric-acid nanoparticles for boron neutron capture therapy","volume":"16","author":"Chan","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apradiso.2026.112838_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/biology10040334","article-title":"Salvage boron neutron capture therapy for malignant brain tumor patients in compliance with emergency and compassionate use: evaluation of 34 cases in Taiwan","volume":"10","author":"Chen","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.apradiso.2026.112838_bib26","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.3390\/curroncol29100622","article-title":"Boron neutron capture therapy: clinical application and research progress","volume":"29","author":"Cheng","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.apradiso.2026.112838_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19258-5","article-title":"First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness","volume":"8","author":"Cirrone","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.apradiso.2026.112838_bib28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/med.21964","article-title":"Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment","volume":"43","author":"Coghi","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkab046","article-title":"Moving forward in the next decade: radiation oncology sciences for patient-centered cancer care","volume":"5","author":"Coleman","year":"2021","journal-title":"JNCI Cancer Spectr."},{"issue":"7","key":"10.1016\/j.apradiso.2026.112838_bib30","doi-asserted-by":"crossref","DOI":"10.1063\/1.3556951","article-title":"Nuclear magnetic resonance study of Gd-based nanoparticles to tag boron compounds in boron neutron capture therapy","volume":"109","author":"Corti","year":"2011","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.apradiso.2026.112838_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1137\/21M1390578","article-title":"Monte Carlo methods for the neutron transport equation","volume":"10","author":"Cox","year":"2022","journal-title":"SIAM\/ASA J. Uncertain. Quantification"},{"key":"10.1016\/j.apradiso.2026.112838_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13543776.2019.1630379","article-title":"A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications","volume":"29","author":"Crocetti","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.apradiso.2026.112838_bib33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.apsb.2021.08.013","article-title":"Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas","volume":"12","author":"Cui","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.apradiso.2026.112838_bib34","doi-asserted-by":"crossref","DOI":"10.1515\/ract-2021-1137","article-title":"China's radiopharmaceuticals on expressway: 2014\u20132021","author":"Cui","year":"2022","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.apradiso.2026.112838_bib35","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3390\/molecules27092615","article-title":"Boron chemicals in drug discovery and development: synthesis and medicinal perspective","volume":"27","author":"Das","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.apradiso.2026.112838_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010093","article-title":"Recent development of radiofluorination of boron agents for boron Neutron capture therapy of tumor: creation of 18F-Labeled C-F and B-F linkages","volume":"16","author":"Deng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apradiso.2026.112838_bib37","series-title":"Frontiers in Boron-based Medicinal Chemistry","first-page":"63","article-title":"Dendritic and nanostructured boron compounds for boron Neutron capture therapy","author":"Dey","year":"2023"},{"key":"10.1016\/j.apradiso.2026.112838_bib38","article-title":"Fluorinated BPA derivatives enhanced 10B delivery in tumors","volume":"B","author":"Ding","year":"2024","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib39","doi-asserted-by":"crossref","DOI":"10.1139\/cjp-2022-0266","article-title":"Boron neutron capture therapy in the new Age of accelerator-based neutron production and preliminary progress in Canada","author":"Dziura","year":"2023","journal-title":"Can. J. Phys."},{"key":"10.1016\/j.apradiso.2026.112838_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/app14031171","article-title":"Fluorescence in situ hybridization-based chromosome aberration analysis unveils the mechanistic basis for boron-neutron capture therapy's radiobiological effectiveness","author":"Elia","year":"2024","journal-title":"Appl. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib41","series-title":"List of Abstracts","first-page":"538","article-title":"P27\u2013Others","author":"Ergen","year":"2012"},{"key":"10.1016\/j.apradiso.2026.112838_bib42","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3390\/pharmaceutics14122703","article-title":"Key parameters for the rational design, synthesis, and functionalization of biocompatible mesoporous Silica nanoparticles","volume":"14","author":"Florensa","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apradiso.2026.112838_bib43","series-title":"EPJ Web of Conferences","article-title":"IAEA nuclear science and instrumentation laboratory: support to IAEA member states and recent developments","author":"Foulon","year":"2020"},{"key":"10.1016\/j.apradiso.2026.112838_bib44","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/cells9102149","article-title":"In vitro studies to define the cell-surface and intracellular targets of polyarginine-conjugated sodium borocaptate as a potential delivery agent for boron neutron capture therapy","volume":"9","author":"Fujimura","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112881","article-title":"Boron Neutron Capture Therapy (BNCT) for cutaneous malignant melanoma using 10B-p-Boronophenylalanine (BPA) with special reference to the radiobiological basis and clinical results","volume":"10","author":"Fukuda","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112883","article-title":"Response of normal tissues to Boron Neutron Capture Therapy (BNCT) with 10B-Borocaptate sodium (BSH) and 10B-Paraboronophenylalanine (BPA)","volume":"10","author":"Fukuda","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109308","article-title":"Pharmacokinetics of 10B-p-boronophenylalanine (BPA) in the blood and tumors in human patients: a critical review with special reference to tumor-to-blood (T\/B) ratios using resected tumor samples","volume":"166","author":"Fukuda","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112838_bib48","series-title":"Boron-Based Compounds: Potential and Emerging Applications in Medicine","article-title":"Nanostructured boron compounds for Boron Neutron Capture Therapy (BNCT) in cancer treatment","author":"Gao","year":"2018"},{"key":"10.1016\/j.apradiso.2026.112838_bib49","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.2174\/0929867325666180926150403","article-title":"Structural and biological overview of boron-containing amino acids in the medicinal chemistry field","volume":"26","author":"Garc\u00eda","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib50","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1039\/D0EN00194E","article-title":"Opportunities for nanotechnology to enhance electrochemical treatment of pollutants in potable water and industrial wastewater\u2013a perspective","volume":"7","author":"Garcia-Segura","year":"2020","journal-title":"Environ. Sci. Nano"},{"key":"10.1016\/j.apradiso.2026.112838_bib51","series-title":"C6 Cell Line : the Gold Standard in Glioma Research","first-page":"105","author":"Giakoumettis","year":"2018"},{"key":"10.1016\/j.apradiso.2026.112838_bib52","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.drudis.2020.04.013","article-title":"Theranostic application of nanoemulsions in chemotherapy","volume":"25","author":"Gorain","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.apradiso.2026.112838_bib53","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1021\/acs.jpca.0c02249","article-title":"Novel computer architectures and quantum chemistry","volume":"124","author":"Gordon","year":"2020","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.apradiso.2026.112838_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2022.129698","article-title":"A DFT study on the therapeutic potential of carbon nanostructures as sensors and drug delivery carriers for curcumin molecule: NBO and QTAIM analyses","volume":"651","author":"Hadi","year":"2022","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"10.1016\/j.apradiso.2026.112838_bib55","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.3390\/ijms21113922","article-title":"Investigation of some antiviral N-heterocycles as COVID 19 drug: molecular docking and DFT calculations","volume":"21","author":"Hagar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib56","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.bmcl.2018.03.075","article-title":"Catalytic asymmetric synthesis of \u03b1-methyl-p-boronophenylalanine","volume":"28","author":"Harada","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.apradiso.2026.112838_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119272","article-title":"The capabilities of nanoelectronic 2-D materials for bio-inspired computing and drug delivery indicate their significance in modern drug design","volume":"279","author":"Hassanzadeh","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-021-01939-7","article-title":"The basis and advances in clinical application of boron neutron capture therapy","volume":"16","author":"He","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.apradiso.2026.112838_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/jfb14040181","article-title":"Acute and subacute toxicity evaluation of Erythrocyte membrane-coated boron nitride nanoparticles","volume":"14","author":"He","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.apradiso.2026.112838_bib60","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.21873\/anticanres.13343","article-title":"11Boron delivery agents for boron proton-capture enhanced proton therapy","volume":"39","author":"Hidegh\u00e9ty","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1023201308434","article-title":"Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial","volume":"62","author":"Hidegh\u00e9ty","year":"2007","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.apradiso.2026.112838_bib62","first-page":"1","article-title":"Critical knowledge gaps and research priorities in global soil salinity","volume":"169","author":"Hopmans","year":"2021","journal-title":"Adv. Agron."},{"key":"10.1016\/j.apradiso.2026.112838_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fchem.2020.00571","article-title":"Peptide-drug conjugates and their targets in advanced cancer therapies","volume":"8","author":"Hoppenz","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib64","series-title":"Boron Science: New Technologies and Applications","author":"Hosmane","year":"2011"},{"key":"10.1016\/j.apradiso.2026.112838_bib65","article-title":"Boron and gadolinium neutron capture therapy for cancer treatment","author":"Hosmane","year":"2012","journal-title":"World Scientific"},{"key":"10.1016\/j.apradiso.2026.112838_bib66","volume":"vol. 4","year":"2018"},{"key":"10.1016\/j.apradiso.2026.112838_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2019.213139","article-title":"Boron agents for neutron capture therapy","volume":"405","author":"Hu","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib68","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1002\/mp.15864","article-title":"Design of a filtration system to improve the dose distribution of an accelerator\u2010based neutron capture therapy system","volume":"49","author":"Hu","year":"2022","journal-title":"Med. Phys."},{"key":"10.1016\/j.apradiso.2026.112838_bib69","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/erm.2022.7","article-title":"Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT)","volume":"24","author":"Hughes","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib70","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1039\/C6NJ03894H","article-title":"Magnetic nanocomposites of boron and vitamin C","volume":"41","author":"Icten","year":"2017","journal-title":"New J. Chem."},{"issue":"14","key":"10.1016\/j.apradiso.2026.112838_bib71","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/zaac.201600181","article-title":"Production of Magnetic Nano\u2010bioconjugates via Ball Milling of Commercial Boron Powder with Biomolecules","volume":"642","author":"Icten","year":"2016","journal-title":"Zeitschrift f\u00fcr anorganische und allgemeine Chemie"},{"key":"10.1016\/j.apradiso.2026.112838_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.msec.2018.06.042","article-title":"Gadolinium borate and iron oxide bioconjugates: nanocomposites of next generation with multifunctional applications","volume":"92","author":"Icten","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.apradiso.2026.112838_bib73","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1039\/D1NJ01960K","article-title":"Spectroscopic, computational and molecular docking study of Cu (ii) complexes with flavonoids: from cupric ion binding to DNA intercalation","volume":"45","author":"\u0160imunkov\u00e1","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14338\/IJPT-22-00002.1","article-title":"A review of Boron Neutron capture therapy: its history and Current challenges","volume":"9","author":"Jin","year":"2022","journal-title":"International Journal of Particle Therapy"},{"key":"10.1016\/j.apradiso.2026.112838_bib75","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.apradiso.2011.03.035","article-title":"Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy","volume":"69","author":"Kabalka","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112838_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/187152006776119144","article-title":"The synthesis and use of boronated amino acids for boron neutron capture therapy","volume":"6","author":"Kabalka","year":"2006","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-4615-3384-9_47","article-title":"Synthesis and properties of tetrakis-carborane-carboxylate esters of 2, 4-bis-(\u03b1, \u03b2-dihydroxyethyl) deuteroporphyrin IX","author":"Kahl","year":"1992","journal-title":"Prog. neutron capture Ther. cancer"},{"key":"10.1016\/j.apradiso.2026.112838_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.apradiso.2026.112838_bib79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/biology11010138","article-title":"In vivo accelerator-based boron neutron capture therapy for spontaneous tumors in large animals: case series","volume":"11","author":"Kanygin","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.apradiso.2026.112838_bib80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/vetsci10040274","article-title":"Gadolinium neutron capture therapy for cats and dogs with spontaneous tumors using Gd-DTPA","volume":"10","author":"Kanygin","year":"2023","journal-title":"Vet. Sci."},{"issue":"5","key":"10.1016\/j.apradiso.2026.112838_bib81","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s12553-024-00862-7","article-title":"The current status and future perspectives of clinical boron neutron capture therapy trials","volume":"14","author":"Karihtala","year":"2024","journal-title":"Heat Technol."},{"issue":"21","key":"10.1016\/j.apradiso.2026.112838_bib82","doi-asserted-by":"crossref","first-page":"20564","DOI":"10.1002\/cam4.6635","article-title":"Correlation between L-amino acid transporter 1 expression and 4-borono-2-18F-fluoro-phenylalanine accumulation in humans","volume":"12","author":"Kashihara","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041076","article-title":"Molecular targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)","volume":"26","author":"Kaufman","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.apradiso.2026.112838_bib84","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11060-010-0376-5","article-title":"Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors","volume":"103","author":"Kawabata","year":"2011","journal-title":"J. Neuro Oncol."},{"issue":"12","key":"10.1016\/j.apradiso.2026.112838_bib85","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/batteries11120443","article-title":"Boron-Doped Bamboo-Derived Porous Carbon via Dry Thermal Treatment for Enhanced Electrochemical Performance","volume":"11","author":"Kim","year":"2025","journal-title":"Batteries"},{"key":"10.1016\/j.apradiso.2026.112838_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles","author":"Kumar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib87","article-title":"Atomistic simulations of pristine and nanoparticle reinforced hydrogels: a review","volume":"e1655","author":"Kumar","year":"2023","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121861","article-title":"One step synthesis of 10B-enriched 10BPO4 nanoparticles for effective boron neutron capture therapeutic treatment of recurrent head-and-neck tumor","volume":"290","author":"Kuthala","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apradiso.2026.112838_bib89","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/ijms23031641","article-title":"Modernistic and emerging developments of nanotechnology in glioblastoma-targeted Theranostic applications","volume":"23","author":"Lakshmi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib90","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1039\/D0CC06557A","article-title":"A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT)","volume":"57","author":"Lamba","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213699","article-title":"In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy","volume":"155","author":"Lan","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.apradiso.2026.112838_bib92","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.3390\/ijms24054978","article-title":"Advances in Boron Neutron Capture Therapy (BNCT) for recurrent intracranial meningioma","volume":"24","author":"Lan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib93","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/RLU.0000000000006047","article-title":"Clinical utility of fluciclovine PET in BNCT for recurrent high-grade glioma","volume":"50","author":"Lan","year":"2025","journal-title":"Clin. Nucl. Med."},{"issue":"10","key":"10.1016\/j.apradiso.2026.112838_bib94","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s00259-021-05227-0","article-title":"First-in-human study of an 18F-labeled boramino acid: a new class of PET tracers","volume":"48","author":"Lan","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"4","key":"10.1016\/j.apradiso.2026.112838_bib95","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/pharmaceutics15041269","article-title":"Biomimetic boron nitride nanoparticles for targeted drug delivery and enhanced antitumor activity","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apradiso.2026.112838_bib96","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jconrel.2020.08.064","article-title":"Functional gadolinium-based nanoscale systems for cancer theranostics","volume":"329","author":"Li","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.apradiso.2026.112838_bib97","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/acs.bioconjchem.9b00578","article-title":"A metabolically stable boron-derived tyrosine serves as a theranostic agent for positron emission tomography guided boron neutron capture therapy","volume":"30","author":"Li","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.apradiso.2026.112838_bib98","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41467-022-29780-w","article-title":"Boron encapsulated in a liposome can be used for combinational neutron capture therapy","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib99","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41467-022-29780-w","article-title":"Boron encapsulated in a liposome can be used for combinational neutron capture therapy","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.apradiso.2026.112838_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118644","article-title":"Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin","volume":"276","author":"Li","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.apradiso.2026.112838_bib101","article-title":"Advances in clinical trials of Boron Neutron capture therapy","volume":"9","author":"Li","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.apradiso.2026.112838_bib102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.apradiso.2026.112838_bib103","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.21037\/qims-23-1769","article-title":"Prognostic assessment of 18F-boronophenylalanine positron emission tomography (BPA-PET) in salvage boron neutron capture therapy for malignant brain tumors","volume":"14","author":"Lin","year":"2023","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.apradiso.2026.112838_bib104","article-title":"Aptamer-drug conjugates: new probes for imaging and targeted therapy","author":"Liu","year":"2022","journal-title":"Biosens. Bioelectron. X"},{"key":"10.1016\/j.apradiso.2026.112838_bib105","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.apradiso.2026.112838_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500694","article-title":"Boramino acid as a marker for amino acid transporters","volume":"1","author":"Liu","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.apradiso.2026.112838_bib107","series-title":"Development of Novel Tumor-Targeted Compounds for Boron Neutron Capture Therapy","author":"Luderer","year":"2019"},{"key":"10.1016\/j.apradiso.2026.112838_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102773","article-title":"Precise delivery of 10B at cellular resolution in vivo enhances boron neutron capture therapy effect","author":"Lv","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.apradiso.2026.112838_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000193","article-title":"Nanoparticle\u2010Based activatable probes for bioimaging","volume":"5","author":"Ma","year":"2021","journal-title":"Adv. Biol."},{"key":"10.1016\/j.apradiso.2026.112838_bib110","series-title":"Carborane-Appended Levodopa for Prostate-specific Membrane Antigen and Boron Neutron Capture Therapy","author":"Macias","year":"2021"},{"issue":"3","key":"10.1016\/j.apradiso.2026.112838_bib111","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00411-025-01130-6","article-title":"Synergistic effects of lead borosilicate waste glass on the mechanical and radiation shielding properties of cement-bitumen composites","volume":"64","author":"Maher","year":"2025","journal-title":"Radiat. Environ. Biophys."},{"key":"10.1016\/j.apradiso.2026.112838_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.676575","article-title":"Molecular mechanisms of specific cellular DNA damage response and repair induced by the mixed radiation field during Boron Neutron capture therapy","volume":"11","author":"Maliszewska-Olejniczak","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.apradiso.2026.112838_bib113","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acs.molpharmaceut.0c00917","article-title":"Exploring the biochemical foundations of a successful GLUT1-targeting strategy to BNCT: chemical synthesis and in vitro evaluation of the entire positional isomer library of ortho-carboranylmethyl-bearing glucoconjugates","volume":"18","author":"Matovic","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.apradiso.2026.112838_bib114","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/jpm11080825","article-title":"A critical review of radiation therapy: from particle beam therapy (proton, carbon, and BNCT) to beyond","volume":"11","author":"Matsumoto","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib115","series-title":"Neutron Laue diffraction-a Spotted History, a Scintillating Future","author":"McIntyre","year":"2020"},{"key":"10.1016\/j.apradiso.2026.112838_bib116","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2176\/nmc.ra.2015-0297","article-title":"Boron neutron capture therapy for malignant brain tumors","volume":"56","author":"Miyatake","year":"2016","journal-title":"Neurol. Med.-Chir."},{"key":"10.1016\/j.apradiso.2026.112838_bib117","series-title":"Monte Carlo Calculations in Nuclear Medicine","article-title":"The Monte Carlo method as a design tool in boron neutron capture therapy","author":"Moghaddasi","year":"2022"},{"key":"10.1016\/j.apradiso.2026.112838_bib118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0076-6879(09)65010-2","article-title":"Liposomal boron delivery for neutron capture therapy","volume":"465","author":"Nakamura","year":"2009","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.apradiso.2026.112838_bib119","first-page":"3","article-title":"Antibody-drug conjugates: possibilities and challenges","volume":"11","author":"Nejadmoghaddam","year":"2019","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.apradiso.2026.112838_bib120","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.6","article-title":"Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair","volume":"24","author":"Nikitaki","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.apradiso.2026.112838_bib121","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/ijms24010306","article-title":"Aptamers for addressed boron delivery in BNCT: effect of boron cluster attachment site on functional activity","volume":"24","author":"Novopashina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133277","article-title":"Multi-Functional boron-delivery agents for boron Neutron capture therapy of cancers","volume":"15","author":"Oloo","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.apradiso.2026.112838_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114724","article-title":"Recent advances in long-acting drug delivery systems for anticancer drug","author":"Pacheco","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib124","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/acs.accounts.9b00336","article-title":"Fluxional boron clusters: from theory to reality","volume":"52","author":"Pan","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/pharmaceutics12121198","article-title":"Nanodelivery systems targeting epidermal growth factor receptors for glioma management","volume":"12","author":"Paranthaman","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apradiso.2026.112838_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105461","article-title":"Micelleplex-based nucleic acid therapeutics: from targeted stimuli-responsiveness to nanotoxicity and regulation","volume":"153","author":"Pereira-Silva","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib127","first-page":"152","article-title":"Systems biology approach to investigate biomarkers, boron-10 carriers, and mechanisms useful for improving boron neutron capture therapy","volume":"38","author":"Perico","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.apradiso.2026.112838_bib128","article-title":"Tolerance of normal brain tissue to boron neutron capture irradiation","author":"Philipp","year":"2004","journal-title":"Petten: Nuclear Research and Consultancy Group (NRG)"},{"issue":"14","key":"10.1016\/j.apradiso.2026.112838_bib129","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1039\/D0PY01392G","article-title":"Polymers and boron neutron capture therapy (BNCT): a potent combination","volume":"12","author":"Pitto-Barry","year":"2021","journal-title":"Polymer Chemistry"},{"key":"10.1016\/j.apradiso.2026.112838_bib130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/biology10030174","article-title":"A novel approach to design and evaluate BNCT neutron beams combining physical, radiobiological, and dosimetric figures of merit","volume":"10","author":"Postuma","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.apradiso.2026.112838_bib131","series-title":"Functional Materials in Biomedical Applications","first-page":"135","article-title":"Polymeric Stimuli responsive Theranostic agents","author":"Psarrou","year":"2023"},{"key":"10.1016\/j.apradiso.2026.112838_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cells13242065","article-title":"Current insights into the radiobiology of Boron Neutron capture therapy and the potential for further improving biological effectiveness","volume":"13","author":"Punshon","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.matpr.2022.12.181","article-title":"Boron neutron capture therapy: history and recent advances","author":"Purohit","year":"2022","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.apradiso.2026.112838_bib134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/inorganics7050059","article-title":"Potential of MRI in radiotherapy mediated by small conjugates and nanosystems","volume":"7","author":"Putri Fauzia","year":"2019","journal-title":"Inorganics"},{"key":"10.1016\/j.apradiso.2026.112838_bib135","article-title":"Janus nanoparticles: new generation of multifunctional nanocarriers in drug delivery, bioimaging and theranostics","volume":"18","author":"Rahiminezhad","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.apradiso.2026.112838_bib136","series-title":"Pharmaceutical Applications of Dendrimers","first-page":"291","article-title":"Dendrimers for diagnostic applications","author":"Rai","year":"2020"},{"key":"10.1016\/j.apradiso.2026.112838_bib137","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.3c01265","article-title":"Boronotyrosine, a borylated amino acid mimetic with enhanced solubility, tumor boron delivery, and retention for the Re-emerging boron neutron capture therapy field","author":"Raitano","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib138","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.drudis.2021.04.008","article-title":"Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors","volume":"26","author":"Reddy","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.apradiso.2026.112838_bib139","series-title":"Approaches to the Purification, Analysis and Characterization of Antibody-based Therapeutics","first-page":"1","article-title":"LC-MS characterization of antibody-based therapeutics: recent highlights and future prospects","author":"Robotham","year":"2020"},{"key":"10.1016\/j.apradiso.2026.112838_bib140","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/cells10113225","article-title":"A boron delivery antibody (BDA) with boronated specific residues: new perspectives in boron neutron capture therapy from an in silico investigation","volume":"10","author":"Rondina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib141","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/acsnano.1c10550","article-title":"Transforming nuclear medicine with nanoradiopharmaceuticals","volume":"16","author":"Roy","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.apradiso.2026.112838_bib142","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.2147\/IJN.S516534","article-title":"Functionalized boron carbide nanoparticles as active boron delivery agents dedicated to boron Neutron capture therapy","volume":"20","author":"Rudawska","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.apradiso.2026.112838_bib143","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3390\/su14063525","article-title":"Asphaltene or polyvinylchloride waste blended with cement to produce a sustainable material used in nuclear safety","volume":"14","author":"Saleh","year":"2022","journal-title":"Sustainability"},{"key":"10.1016\/j.apradiso.2026.112838_bib144","series-title":"Handbook of Cultural Heritage Analysis","first-page":"375","article-title":"Cultural Heritage Project at Australian nuclear science and technology Organisation (ANSTO)","author":"Salvemini","year":"2022"},{"key":"10.1016\/j.apradiso.2026.112838_bib145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/life11040330","article-title":"Theranostics in boron neutron capture therapy","volume":"11","author":"Sauerwein","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.apradiso.2026.112838_bib146","series-title":"Neutron Capture Therapy: Principles and Applications","year":"2012"},{"key":"10.1016\/j.apradiso.2026.112838_bib147","article-title":"Boron neutron capture therapy at a crossroads: translational gap and emerging delivery agents","volume":"32","author":"Selg","year":"2026","journal-title":"Chemistry (Weinheim an Der Bergstrasse, Germany)"},{"key":"10.1016\/j.apradiso.2026.112838_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.572754","article-title":"Monitoring immune responses in IgA nephropathy: biomarkers to guide management","volume":"11","author":"Selvaskandan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.apradiso.2026.112838_bib149","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3390\/cancers14123009","article-title":"Exploring the biological and physical basis of Boron Neutron Capture Therapy (BNCT) as a promising treatment frontier in breast cancer","volume":"14","author":"Seneviratne","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apradiso.2026.112838_bib150","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/cells12101398","article-title":"Next-Generation boron drugs and rational translational studies driving the revival of BNCT","volume":"12","author":"Seneviratne","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.apradiso.2026.112838_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-27625-0","article-title":"A novel pH sensitive theranostic PLGA nanoparticle for boron neutron capture therapy in mesothelioma treatment","volume":"13","author":"Sforzi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.apradiso.2026.112838_bib152","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/09553002.2024.2373746","article-title":"A clinician's perspective on boron neutron capture therapy: promising advances, ongoing trials, and future outlook","volume":"100","author":"Shen","year":"2024","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.apradiso.2026.112838_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2025.112230","article-title":"Optimization of a collimator design for an epithermal neutron source based on 7Li (p,n) be reaction and 2.5 MeV protons for BNCT","volume":"226","author":"Shuai","year":"2025","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112838_bib154","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/bams-2021-0140","article-title":"Combined BNCT and PET for theranostics","volume":"17","author":"Silarski","year":"2021","journal-title":"Bio. Algorithm Med. Syst."},{"key":"10.1016\/j.apradiso.2026.112838_bib155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ma14010004","article-title":"Radiolabeled gold nanoparticles for imaging and therapy of cancer","volume":"14","author":"Silva","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.apradiso.2026.112838_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122865","article-title":"Clinical viability of Boron Neutron capture therapy for personalized radiation treatment","volume":"14","author":"Skwierawska","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.apradiso.2026.112838_bib157","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1021\/acs.jpcb.1c05805","article-title":"Interactions of the A\u03b2 (1\u201342) peptide with boron nitride nanoparticles of varying curvature in an aqueous medium: different pathways to inhibit \u03b2-Sheet Formation","volume":"125","author":"Sorout","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.apradiso.2026.112838_bib158","article-title":"Priority research directions in tumor-targeted boron delivery for boron Neutron capture therapy","author":"Sycheva","year":"2025","journal-title":"Journal of oncology: diagnostic radiology and radiotherapy"},{"key":"10.1016\/j.apradiso.2026.112838_bib159","article-title":"Transcriptomic data analysis of melanocytes and melanoma cell lines of LAT transporter genes for precise medicine","volume":"18","author":"Szczepanek","year":"2022","journal-title":"Bio. Algorithm Med. Syst."},{"key":"10.1016\/j.apradiso.2026.112838_bib160","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1038\/s41598-020-62268-5","article-title":"Enhancement of radiation effectiveness in proton therapy: comparison between fusion and fission methods and further approaches","volume":"10","author":"Tabbakh","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.apradiso.2026.112838_bib161","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1140\/epjp\/s13360-023-04150-7","article-title":"Enhanced biological effectiveness with carbon nanoparticles in proton therapy: a simulation study","volume":"138","author":"Tabbakh","year":"2023","journal-title":"The European Physical Journal Plus"},{"key":"10.1016\/j.apradiso.2026.112838_bib162","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1667\/0033-7587(2001)156[0118:BDBAAP]2.0.CO;2","article-title":"Boronated dipeptide borotrimethylglycylphenylalanine as a potential boron carrier in boron neutron capture therapy for malignant brain tumors","volume":"156","author":"Takagaki","year":"2001","journal-title":"Radiat. Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib163","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5650\/jos.ess19218","article-title":"Polyborane-encapsulated PEGylated liposomes prepared using post-insertion technique for boron neutron capture therapy","volume":"68","author":"Takeuchi","year":"2019","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib164","series-title":"Seminars in Cancer Biology","article-title":"Artificial intelligence aids in development of nanomedicines for cancer management","author":"Tan","year":"2023"},{"key":"10.1016\/j.apradiso.2026.112838_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.925671","article-title":"Evaluation of pharmacokinetics of boronophenylalanine and its uptakes in gastric cancer","volume":"12","author":"Tang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.apradiso.2026.112838_bib166","article-title":"Boron-Containing mesoporous silica nanoparticles with effective delivery and targeting of liver cancer cells for Boron Neutron capture therapy","author":"Tang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.apradiso.2026.112838_bib167","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apradiso.2026.112838_bib168","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/9781119275602.ch3.1","article-title":"Twenty years of research on 3\u2010Carboranyl thymidine analogs (3CTAs) A critical perspective","author":"Tjarks","year":"2018","journal-title":"Boron\u2010Based Compd. Potential Emerg. Appl. Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib169","article-title":"Molecular targeting and treatment of EGFRvIII-Positive gliomas using boronated monoclonal antibody L8A4","volume":"12","author":"Tjarks","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001632","article-title":"Biocompatible iron\u2013boron nanoparticles designed for neutron capture therapy guided by magnetic resonance imaging","volume":"10","author":"Torresan","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.apradiso.2026.112838_bib171","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/biology12030377","article-title":"Improved boron neutron capture therapy using Integrin \u03b1v\u03b23-Targeted long-retention-type boron carrier in a F98 rat glioma model","volume":"12","author":"Tsujino","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.apradiso.2026.112838_bib172","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.mencom.2021.09.022","article-title":"Liposomes loaded with lipophilic derivative of closo-carborane as a potential boron delivery system for boron neutron capture therapy of tumors","volume":"31","author":"Tsygankova","year":"2021","journal-title":"Mendeleev Commun."},{"issue":"42","key":"10.1016\/j.apradiso.2026.112838_bib173","doi-asserted-by":"crossref","DOI":"10.1002\/app.56094","article-title":"Self\u2010healing, low oil leakage and recyclable thermally conductive Al2O3\/boron nitride@siloxane composites based on reversible dynamic network","volume":"141","author":"Tu","year":"2024","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib174","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41392-022-00917-z","article-title":"Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia\/reperfusion","volume":"7","author":"Tuo","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.apradiso.2026.112838_bib175","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.2174\/0929867326666190603123838","article-title":"Periphery Decorated and Core Initiated Neutral and Polyanionic Borane large molecules: forthcoming and promising properties for medicinal applications","volume":"26","author":"Vi\u00f1as","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib176","doi-asserted-by":"crossref","first-page":"343","DOI":"10.34133\/bmr.0343","article-title":"Boosting boron neutron capture therapy through ferroptosis activation with a biomimetic nanoenhancer","volume":"30","author":"Wang","year":"2026","journal-title":"Biomater. Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214326","article-title":"Specific recognitions of multivalent cyclotriphosphazene derivatives in sensing, imaging, theranostics, and biomimetic catalysis","volume":"454","author":"Wang","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib178","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/acs.molpharmaceut.9b00464","article-title":"Synthesis and initial biological evaluation of boron-containing prostate-specific membrane antigen ligands for treatment of prostate cancer using boron neutron capture therapy","volume":"16","author":"Wang","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.apradiso.2026.112838_bib179","doi-asserted-by":"crossref","DOI":"10.1111\/j.1582-4934.2009.00856.x","article-title":"EORTC trial 11001: distribution of two 10B\u2010compounds in patients with squamous cell carcinoma of head and neck, a translational research\/phase 1 trial","volume":"13","author":"Wittig","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib180","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.apradiso.2011.02.046","article-title":"Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention","volume":"69","author":"Wittig","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112838_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24171","article-title":"Targeting of peptide\u2010binding receptors on cancer cells with peptide\u2010drug conjugates","volume":"112","author":"Worm","year":"2020","journal-title":"Pept. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib182","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-06-2399","article-title":"Molecular targeting and treatment of an epidermal growth factor receptor\u2013positive glioma using boronated cetuximab","volume":"13","author":"Wu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib183","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11095-021-03072-2","article-title":"Co-delivery using pH-sensitive liposomes to pancreatic cancer cells: the effects of curcumin on cellular concentration and pharmacokinetics of gemcitabine","volume":"38","author":"Xu","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib184","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1039\/D5RA00734H","article-title":"Boron carbide nanoparticles for boron neutron capture therapy","volume":"15","author":"Xu","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.apradiso.2026.112838_bib185","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/9781119275602.ch3.2","article-title":"Recent advances in boron delivery agents for boron neutron capture therapy (BNCT)","author":"Xuan","year":"2018","journal-title":"Boron\u2010Based Compd. Potential Emerg. Appl. Med."},{"key":"10.1016\/j.apradiso.2026.112838_bib186","series-title":"Artificial Intelligence and the Fourth Industrial Revolution","first-page":"73","article-title":"Role of AI in the advancement of drug discovery and development","author":"Yadav","year":"2022"},{"key":"10.1016\/j.apradiso.2026.112838_bib187","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11060-009-9945-x","article-title":"Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors","volume":"95","author":"Yang","year":"2009","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.apradiso.2026.112838_bib188","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.apradiso.2009.03.030","article-title":"Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents","volume":"67","author":"Yang","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112838_bib189","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.2174\/0929867325666180904105212","article-title":"The current status and perspectives of delivery strategy for boronbased drugs","volume":"26","author":"Yinghuai","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.apradiso.2026.112838_bib190","article-title":"Toward a better regeneration through implant\u2010mediated immunomodulation: harnessing the immune responses","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.apradiso.2026.112838_bib191","article-title":"Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.apradiso.2026.112838_bib192","article-title":"Pharmacokinetic, biodistribution, safety and efficacy studies of borophenylalanine (BPA) in BNCT in hepatocellular carcinoma cells and tumor-bearing mouse model","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.apradiso.2026.112838_bib193","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1515\/mr-2023-0013","article-title":"Nanostructured boron agents for boron neutron capture therapy: a review of recent patents","volume":"3","author":"Zhang","year":"2023","journal-title":"Med. Rev."},{"issue":"3","key":"10.1016\/j.apradiso.2026.112838_bib194","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/med.22093","article-title":"Comparison of radionuclide drug conjugates with boron neutron capture therapy: an overview of targeted charged particle radiation therapy","volume":"45","author":"Zhang","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.apradiso.2026.112838_bib195","first-page":"4668","article-title":"Boron-containing nucleosides as tools for boron-neutron capture therapy","volume":"11","author":"Zharkov","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.apradiso.2026.112838_bib196","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38648-y","article-title":"Introduction to the Monte Carlo dose engine COMPASS for BNCT","volume":"13","author":"Zhong","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.apradiso.2026.112838_bib197","series-title":"Frontiers in Boron-based Medicinal Chemistry","first-page":"1","article-title":"General boron chemistry and medicinal applications","author":"Zhu","year":"2023"},{"key":"10.1016\/j.apradiso.2026.112838_bib198","series-title":"Frontiers in Boron-based Medicinal Chemistry","article-title":"Application of theranostic technology in Boron Neutron capture therapy","author":"Zhu","year":"2023"},{"issue":"4","key":"10.1016\/j.apradiso.2026.112838_bib199","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1515\/pac-2017-0903","article-title":"Nanostructured boron compounds for cancer therapy","volume":"90","author":"Zhu","year":"2017","journal-title":"Pure Appl. Chem."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804326004227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804326004227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:43Z","timestamp":1788779863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804326004227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":199,"alternative-id":["S0969804326004227"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112838","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maximizing nuclear capture and fission reactions: The innovative potential of boron delivery agents for neutron capture therapy in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112838"}}